rizatriptan benzoate NDC 68462-468

NDC codes

FDA NDC Directory

Product NDC (as listed)68462-468Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68462-0468Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
68462-468-06	68462046806	6 BOX in 1 CARTON (68462-468-06) / 3 POUCH in 1 BOX (68462-468-46) / 1 BLISTER PACK in 1 POUCH / 1 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACKMarketed from Jul 1, 2013
68462-468-74	68462046874	4 BOX in 1 CARTON (68462-468-74) / 3 POUCH in 1 BOX / 1 BLISTER PACK in 1 POUCH / 1 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACKMarketed from Jul 1, 2013

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): rizatriptan benzoate
Generic name (nonproprietary): rizatriptan benzoate
Active ingredients: Rizatriptan benzoate — 10 mg/1
Dosage form: Tablet, Orally disintegrating
Route: Oral
Labeler: Glenmark Pharmaceuticals Inc., USA
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 201914
Marketing start: Jul 1, 2013
Listing expires: Dec 31, 2026
Other FDA classes: Serotonin 1b Receptor Agonists (Mechanism)Serotonin 1d Receptor Agonists (Mechanism)
Identifiers: Product ID 68462-468_d0d83e24-265b-4802-96e0-e0d18bef299dSPL ID d0d83e24-265b-4802-96e0-e0d18bef299dSPL set ID 4de33a24-db69-444a-b04d-c69ccba57ab2RxCUI 312837, 312839UNII WR978S7QHHUPC 0368462467060, 0368462468067
Pharmacologic class: Serotonin-1b and Serotonin-1d Receptor Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N468462046806 followed by a unit qualifier and the quantity

Package 68462-0468-06. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Sep 14, 2022.

Indications (excerpt from the label)

Rizatriptan benzoate orally disintegrating tablets are indicated for the acute treatment of migraine with or without aura in adults and in pediatric patients 6 to 17 years old. Limitations of Use • Rizatriptan benzoate orally disintegrating tablets should only be used where a clear diagnosis of migraine has been established. If a patient has no response for the first migraine attack treated with rizatriptan benzoate orally disintegrating tablets, the diagnosis of migraine should be reconsidered before rizatriptan benzoate orally disintegrating tablets are administered to treat any subsequent attacks. • Rizatriptan benzoate orally disintegrating tablets are not indicated for use in the manage…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 201914

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 201914
Product	Strength	Form · route	Labeler	Product NDC
rizatriptan benzoate	Rizatriptan benzoate 5 mg/1	Tablet, Orally disintegratingOral	Glenmark Pharmaceuticals Inc., USA	68462-467